141 related articles for article (PubMed ID: 10971375)
21. [Therapy-resistant pyoderma gangrenosum--treatment with mycophenolate mofetil and cyclosporine A].
Michel S; Hohenleutner U; Mohr V; Landthaler M
Hautarzt; 1999 Jun; 50(6):428-31. PubMed ID: 10427512
[TBL] [Abstract][Full Text] [Related]
22. Vulvar pyoderma gangrenosum originating from a healed obstetric laceration.
Reed BG; Shippey S; Kremp A; Belin E
Obstet Gynecol; 2013 Aug; 122(2 Pt 2):452-455. PubMed ID: 23884257
[TBL] [Abstract][Full Text] [Related]
23. Multifocal pyoderma gangrenosum resistant to infliximab in active ulcerative colitis: don't forget the role of cyclosporin.
Sinagra E; Orlando A; Renna S; Maida M; Cottone M
Inflamm Bowel Dis; 2012 Aug; 18(8):E1594-5. PubMed ID: 22038892
[No Abstract] [Full Text] [Related]
24. Accelerated healing of pyoderma gangrenosum in Behçet patient treated with cyclosporine and split thickness skin graft.
Kim DW; Lee BI; Park SH
Ann Plast Surg; 2008 Nov; 61(5):552-4. PubMed ID: 18948785
[TBL] [Abstract][Full Text] [Related]
25. Pyoderma gangrenosum triggered by switching from adalimumab to secukinumab.
Jin K; Matsuzaki Y; Akasaka E; Nakano H; Sawamura D
J Dermatol; 2019 Mar; 46(3):e108-e109. PubMed ID: 30192400
[No Abstract] [Full Text] [Related]
26. Pyoderma Gangrenosum With Ulcerative Colitis Successfully Treated With Ustekinumab.
Piqueras-García J; Sahuquillo-Torralba AJ; Torres-Navarro I; Botella-Estrada R
Actas Dermosifiliogr (Engl Ed); 2019 Nov; 110(9):776-778. PubMed ID: 31151671
[No Abstract] [Full Text] [Related]
27. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
28. Refractory Pyoderma Gangrenosum in a Patient With Crohn's Disease: Complete Response to Ustekinumab.
Nunes G; Patita M; Fernandes V
J Crohns Colitis; 2019 May; 13(6):812-813. PubMed ID: 30535292
[No Abstract] [Full Text] [Related]
29. [Pyoderma gangrenosum and Behçet's disease: a study of two pediatric cases].
Hali F; Khadir K; Chiheb S; Bouayad K; Mikou N; Benchikhi H
Arch Pediatr; 2011 Dec; 18(12):1320-3. PubMed ID: 22030347
[TBL] [Abstract][Full Text] [Related]
30. Sarcoidosis and pyoderma gangrenosum: an exceptional association. The role of trauma and immunosuppressive agents.
Herrero JE; Mascaró JM; Llambrich A; Herrero C
J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):97-9. PubMed ID: 15649201
[TBL] [Abstract][Full Text] [Related]
31. Pyoderma gangrenosum associated with hidradenitis suppurativa.
Ah-Weng A; Langtry JA; Velangi S; Evans CD; Douglas WS
Clin Exp Dermatol; 2005 Nov; 30(6):669-71. PubMed ID: 16197385
[TBL] [Abstract][Full Text] [Related]
32. [Pyoderma gangrenosum is 100 years old. From Louis Brocq to biotherapies].
Farhi D; Wallach D; Avril MF
Rev Prat; 2008 Feb; 58(4):457-61. PubMed ID: 18506988
[No Abstract] [Full Text] [Related]
33. Recalcitrant pyoderma gangrenosum treated with thalidomide.
Federman GL; Federman DG
Mayo Clin Proc; 2000 Aug; 75(8):842-4. PubMed ID: 10943240
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporine in Dermatology.
Kutlubay Z; Erdogan BÇ; Engin B; Serdaroglu S
Skinmed; 2016; 14(2):105-9. PubMed ID: 27319953
[TBL] [Abstract][Full Text] [Related]
35. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis.
Gilmour E; Stewart DG
Br J Dermatol; 2001 Feb; 144(2):397-400. PubMed ID: 11251582
[TBL] [Abstract][Full Text] [Related]
36. [Pyoderma gangrenosum--positive effect of cyclosporin A therapy ].
Krauze E; Lis A; Kamińska-Budzińska G; Wygledowska-Kania M; Pierzchała E; Brzezińska-Wcisło L
Pol Merkur Lekarski; 2002 Oct; 13(76):336-40. PubMed ID: 12557445
[TBL] [Abstract][Full Text] [Related]
37. Failure of sublesional infliximab injection for refractory parastomal pyoderma gangrenosum in a patient with Crohn's disease.
Teich N
Tech Coloproctol; 2014 Oct; 18(10):965-6. PubMed ID: 24965074
[No Abstract] [Full Text] [Related]
38. Postsurgical pyoderma gangrenosum successfully treated with cyclosporine.
Behera B; Chandrashekar L; Thappa DM; Srinivas BH; Pasayat PP; Laroiya I
Indian J Dermatol Venereol Leprol; 2017; 83(3):412. PubMed ID: 27852992
[No Abstract] [Full Text] [Related]
39. [Pyoderma gangrenosum with an atypical location and a rapid response to cyclosporin A].
Ferrer Ríos T; Ramos Lora M; Pallarés Manrique H; Pérez Gómez MB; Garrido Mora M; Carrasco FJ; Domínguez Macías A
Gastroenterol Hepatol; 1999 May; 22(5):227-9. PubMed ID: 10396103
[TBL] [Abstract][Full Text] [Related]
40. Refractory disseminated pyoderma gangrenosum, with dependence on corticosteroids, responding to potassium iodide.
Qiu L; Zheng S; Wu J; Xiao T; Chen HD
Eur J Dermatol; 2012; 22(3):426-7. PubMed ID: 22417688
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
